UltraGreen.ai gains approval to market IC-Flow Imaging System V2 in India, Thailand, Philippines and Bangladesh

SGX Filings

Mar 12

UltraGreen.ai Limited (SGX:ULG) announced on Mar, 12 2026 that its IC-Flow Imaging System V2 has secured regulatory clearances in India, Thailand, the Philippines and Bangladesh, expanding the device’s regulatory footprint to 45 territories worldwide.

The hand-held near-infrared system, designed to visualise tissue perfusion and lymphatic flow during open surgery, is now registered with India’s Central Drugs Standard Control Organisation, Thailand’s Medical Device Control Division, the Philippines’ Centre for Device Regulation, Health and Research, and Bangladesh’s Directorate General of Drug Administration.

UltraGreen.ai said the new approvals strengthen its strategy to broaden access to fluorescence-guided surgery across the Asia-Pacific region, adding to existing clearances in Singapore, Malaysia, New Zealand, the United States and Europe.

Chief Operating Officer Declan Cassells stated that the company can now engage healthcare institutions and distributors in the newly approved markets, while Chief Business Officer (APAC) Quek Mei Ling highlighted the opportunity to develop long-term partnerships and clinical education initiatives in South and Southeast Asia.

UltraGreen.ai develops fluorescence-guided surgery systems and markets the indocyanine green imaging agent Verdye outside North America.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1187495247"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1187495247\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1187495247?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 13:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187495247","market":"sg","top_or_hot":-1,"title":"UltraGreen.ai gains approval to market IC-Flow Imaging System V2 in India, Thailand, Philippines and Bangladesh","media":"SGX Filings","content":"<html><head></head><body><p>UltraGreen.ai Limited (SGX:ULG) announced on Mar, 12 2026 that its IC-Flow Imaging System V2 has secured regulatory clearances in India, Thailand, the Philippines and Bangladesh, expanding the device’s regulatory footprint to 45 territories worldwide.</p>\n<p>The hand-held near-infrared system, designed to visualise tissue perfusion and lymphatic flow during open surgery, is now registered with India’s Central Drugs Standard Control Organisation, Thailand’s Medical Device Control Division, the Philippines’ Centre for Device Regulation, Health and Research, and Bangladesh’s Directorate General of Drug Administration.</p>\n<p>UltraGreen.ai said the new approvals strengthen its strategy to broaden access to fluorescence-guided surgery across the Asia-Pacific region, adding to existing clearances in Singapore, Malaysia, New Zealand, the United States and Europe.</p>\n<p>Chief Operating Officer Declan Cassells stated that the company can now engage healthcare institutions and distributors in the newly approved markets, while Chief Business Officer (APAC) Quek Mei Ling highlighted the opportunity to develop long-term partnerships and clinical education initiatives in South and Southeast Asia.</p>\n<p>UltraGreen.ai develops fluorescence-guided surgery systems and markets the indocyanine green imaging agent Verdye outside North America.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UltraGreen.ai gains approval to market IC-Flow Imaging System V2 in India, Thailand, Philippines and Bangladesh</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUltraGreen.ai gains approval to market IC-Flow Imaging System V2 in India, Thailand, Philippines and Bangladesh\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-03-12 13:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>UltraGreen.ai Limited (SGX:ULG) announced on Mar, 12 2026 that its IC-Flow Imaging System V2 has secured regulatory clearances in India, Thailand, the Philippines and Bangladesh, expanding the device’s regulatory footprint to 45 territories worldwide.</p>\n<p>The hand-held near-infrared system, designed to visualise tissue perfusion and lymphatic flow during open surgery, is now registered with India’s Central Drugs Standard Control Organisation, Thailand’s Medical Device Control Division, the Philippines’ Centre for Device Regulation, Health and Research, and Bangladesh’s Directorate General of Drug Administration.</p>\n<p>UltraGreen.ai said the new approvals strengthen its strategy to broaden access to fluorescence-guided surgery across the Asia-Pacific region, adding to existing clearances in Singapore, Malaysia, New Zealand, the United States and Europe.</p>\n<p>Chief Operating Officer Declan Cassells stated that the company can now engage healthcare institutions and distributors in the newly approved markets, while Chief Business Officer (APAC) Quek Mei Ling highlighted the opportunity to develop long-term partnerships and clinical education initiatives in South and Southeast Asia.</p>\n<p>UltraGreen.ai develops fluorescence-guided surgery systems and markets the indocyanine green imaging agent Verdye outside North America.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ULG.SI","symbol_name":"优创康智有限公司","start_time":0,"source_url":"","article_id":"1187495247","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187495247","pubTimestamp":1773292073,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"UltraGreen.ai Limited (SGX:ULG) announced on Mar, 12 2026 that its IC-Flow Imaging System V2 has secured regulatory clearances in India, Thailand, the Philippines and Bangladesh, expanding the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ULG.SI":"优创康智有限公司"},"translate_title":"UltraGreen.ai获批在印度、泰国、菲律宾和孟加拉国上市IC-Flow成像系统V2","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ULG.SI":1},"content_text":"UltraGreen.ai Limited (SGX:ULG) announced on Mar, 12 2026 that its IC-Flow Imaging System V2 has secured regulatory clearances in India, Thailand, the Philippines and Bangladesh, expanding the device’s regulatory footprint to 45 territories worldwide.\nThe hand-held near-infrared system, designed to visualise tissue perfusion and lymphatic flow during open surgery, is now registered with India’s Central Drugs Standard Control Organisation, Thailand’s Medical Device Control Division, the Philippines’ Centre for Device Regulation, Health and Research, and Bangladesh’s Directorate General of Drug Administration.\nUltraGreen.ai said the new approvals strengthen its strategy to broaden access to fluorescence-guided surgery across the Asia-Pacific region, adding to existing clearances in Singapore, Malaysia, New Zealand, the United States and Europe.\nChief Operating Officer Declan Cassells stated that the company can now engage healthcare institutions and distributors in the newly approved markets, while Chief Business Officer (APAC) Quek Mei Ling highlighted the opportunity to develop long-term partnerships and clinical education initiatives in South and Southeast Asia.\nUltraGreen.ai develops fluorescence-guided surgery systems and markets the indocyanine green imaging agent Verdye outside North America.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":true,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}